A group of blood pressure medications may hold the key to better outcomes for those with COVID-19, marking a significant breakthrough in the treatment of the virus. An exciting new study, involving researchers from across Australia and India, will investigate whether existing blood pressure medications can reduce the risk of severe disease as well as the duration of severe symptoms. Rese.....
Read more

New research is testing a new way to meet the rapidly growing demand for physiotherapy in our public hospitals. A clinical trial at four hospitals, including Hornsby and Royal North Shore, is studying whether some patients can successfully undertake physiotherapy exercises at home and still experience the same benefit provided by attending a hospital clinic. “Demand for physio is increa.....
Read more

Congratulations to Professor David Hunter who’s received a prestigious University of Sydney Vice Chancellor’s award for outstanding research. The Kolling researcher and rheumatology clinician is regarded as the world’s leading expert in osteoarthritis. Professor Hunter’s research has had a significant and lasting impact in the field of osteoarthritis, influencing clinical practice and a.....
Read more

The latest exciting research into musculoskeletal disease has been unveiled during the inaugural Northern Lights showcase. Close to 200 people attended the jam packed event in the Kolling auditorium, including clinicians, researchers and many people living with arthritic pain. RNSH Head of Rheumatology Professor Lyn March addressed the event, detailing the devastating cost of the diseas.....
Read more

Research capabilities within the Kolling Institute have been significantly broadened with new technology to assist the examination of bowel cancer. Representatives from Sydney University, the Kolling and Bowel Cancer Australia attended the official opening of the mass spectrometry core lab – the first of its type on a hospital campus and one of the best analytical facilities in the worl.....
Read more